CAMBIUM ONCOLOGY
Cambium Oncology LLC is a pre-clinical start-up focused on developing and commercializing new immuno-oncology therapeutics that target a novel checkpoint pathway. The company has licensed a patented technology from Emory University to use inhibitory peptides designed against immuno-suppressive vasoactive intestinal peptide (VIP) to cause both in vitro and in vivo activation and proliferation of T cells. Administration of VIP-antagonist peptides trigger a robust cytotoxic T-cell mediated immune response in tumor-bearing animals that resulted in reduction of tumor size and increase in survival time.
CAMBIUM ONCOLOGY
Industry:
Clinical Trials Health Care
Founded:
2018-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.cambiumoncology.com
Status:
Active
Contact:
404-693-7796
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Sitelinks Search Box
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.cambiumoncology.com
- Host name: 143.198.66.95
- IP address: 143.198.66.95
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cambium Oncology"
Cambium Oncology - First in Class Therapeutics for Cancer
Leadership Team. We are motivated drug developers fully committed to deliver innovative medicines to cancer patients. The team brings together over 20 years of expertise in top-notch โฆSee details»
Partnership - Cambium Oncology
The Georgia Research Alliance is an Atlanta, Georgia-based nonprofit organization that coordinates research efforts between Georgia's public and private sectors. ... If you are interested in learning more about how we might โฆSee details»
Cambium Oncology - Crunchbase Company Profile & Funding
Cambium Oncology LLC is a pre-clinical start-up focused on developing and commercializing new immuno-oncology therapeutics that target a novel checkpoint pathway.See details»
Team - Cambium Oncology
Michael Broughton, CPA, CGMA. Michael has served in the audit department of Alumax, now a subsidiary of Alcoa and was a staff accountant with KPMG His BBA, magna cum laude, is from the University of Notre Dame He is the former โฆSee details»
Cambium Oncology - PitchBook
Www.cambiumoncology.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 890 Los Angeles Avenue Northeast; Atlanta, GA 30306; United StatesSee details»
Cambium Oncology LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cambium Oncology LLC of Atlanta, GA. Get the latest business insights from Dun & Bradstreet.See details»
Cambium Oncology - Overview, News & Similar companies
Www.cambiumoncology.com. Revenue. $13M. Industry. Hospitals & Clinics Healthcare. Is this data correct? Popular Searches Cambium Oncology LLC SIC Code 80,801 NAICS Code โฆSee details»
Cambium Oncology Overview | SignalHire Company Profile
Drugs to fight acute myeloid leukemia (AML). Our immunotherapeutics provide 80% cancer-free survival in leukemic mice, reduces the size of pancreatic tumors, and re-activates human T โฆSee details»
Cambium Oncology LLC - Drug pipelines, Patents, Clinical trials
Sep 13, 2024 Explore Cambium Oncology LLC with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Hemic and Lymphatic Diseases, Neoplasms, โฆSee details»
Cambium Oncology - CoBee Company Profile & Funding Rounds
Cambium Oncology LLC is a pre-clinical start-up focused on developing and commercializing new immuno-oncology therapeutics that target a novel checkpoint pathway. The company has โฆSee details»
Cambium Oncology LLC Company Profile -Sales, Contacts, โฆ
Cambium Oncology is in the Oncologist industry within the Health Services sector and has been in business for approximately 6 years.See details»
Cambium Oncology - Products, Competitors, Financials, โฆ
Cambium Oncology focuses on developing first-in-class therapeutics in the biotechnology sector, specifically for cancer treatment. Use the CB Insights Platform to explore Cambium โฆSee details»
Cambium Oncology - Company Profile - Tracxn
Nov 27, 2024 Cambium Oncology - Developer of checkpoint inhibitors for the treatment of solid tumors. Founded by Edmund K Waller in the year 2019. Cambium Oncology has 2860 โฆSee details»
Cambium Oncology LLC Overview - Salary.com
Discover essential details about Cambium Oncology LLC, including address, contact, and journey of our company's evolution.See details»
Cambium Oncology: Employee Directory | ZoomInfo.com
Cambium Oncology Employee Directory . Cambium Oncology corporate office is located in 890 Los Angeles Ave NE, Atlanta, Georgia, 30306, United States and has 1 employees.See details»
Investment Opportunity - Cambium Oncology
Get directly involved in the fight against cancer! Join us and become an investor in Cambium Oncology.In the dynamic field of cancer immunotherapy, the search for more effective โฆSee details»
Publications - Cambium Oncology
November 6, 2023 - Frontiers The magic of small-moleculedrugs during ex vivo expansionin adoptive cell therapy. Read moreSee details»
Cambium Oncology LLC (Cambium Oncology LLC) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
ไบ่งฃCambium Oncology LLC (Cambium Oncology LLC)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็๏ผ็พ็ ้ขๅ:่กๆถฒๅๆทๅทด็ณป็ป็พ็ ๏ผ่ฟ็ค๏ผๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผๆๆฏๅนณๅฐ:ๅฐๅๅญๅ โฆSee details»
Pipeline - Cambium Oncology
© 2023 Cambium Oncology. All Rights ReservedSee details»
Technology - Cambium Oncology
Cancer cells over-express VIP creating immunosuppression that limits anti-cancer immunity. Activated T cells up-regulate VIP receptors. VIP is a conserved pathway in evolution, and โฆSee details»